220 related articles for article (PubMed ID: 31167750)
1. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Sep; 76(3):e67-e68. PubMed ID: 31167750
[No Abstract] [Full Text] [Related]
2. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Takahashi T
Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
[No Abstract] [Full Text] [Related]
3. Reply to Takeshi Takahashi's Letter to the Editor re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol 2021;80;760-2. Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki: Re-envisioning the Value of Clinical Research to Foster the Progress of Evidence-based Urology: The Case of Partial Nephrectomy for cT2 Renal Masses.
Campi R; Bertolo R; Minervini A;
Eur Urol; 2022 Feb; 81(2):e46-e47. PubMed ID: 34887115
[No Abstract] [Full Text] [Related]
4. Reply to Won Ho Kim, Hyun-Kyu Yoon, Chang Wook Jeong's Letter to Editor re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury, Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
Bravi CA
Eur Urol; 2020 Jan; 77(1):e16-e17. PubMed ID: 31590938
[No Abstract] [Full Text] [Related]
5. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
Van Poppel H; Roobol MJ
Eur Urol; 2022 Jan; 81(1):e23-e24. PubMed ID: 34756628
[No Abstract] [Full Text] [Related]
6. Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?
Mollica V; Rizzo A; Massari F
Eur Urol Oncol; 2020 Aug; 3(4):559-560. PubMed ID: 32553708
[No Abstract] [Full Text] [Related]
7. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
Verhagen PCMS; Boevé ER
Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
[No Abstract] [Full Text] [Related]
8. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
[No Abstract] [Full Text] [Related]
9. Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol. 2021;80:760-2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki.
Takahashi T
Eur Urol; 2022 Feb; 81(2):e44-e45. PubMed ID: 34887116
[No Abstract] [Full Text] [Related]
10. Reply to Riuko Ohashi, Arndt Hartmann, Holger Moch, and Guido Martignoni's Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
Avulova S; Cheville JC; Lohse CM; Thompson RH; Potretzke AM
Eur Urol; 2021 Jul; 80(1):e19. PubMed ID: 33875305
[No Abstract] [Full Text] [Related]
11. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
Kim WH; Yoon HK; Jeong CW
Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
[No Abstract] [Full Text] [Related]
12. Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng's Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
Eppler M; Ganjavi C; Abreu A; Gill I; Cacciamani GE
Eur Urol; 2024 Mar; 85(3):e85-e86. PubMed ID: 38182492
[No Abstract] [Full Text] [Related]
13. Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
Bhindi B; Boorjian SA
Eur Urol; 2018 Mar; 73(3):e70-e71. PubMed ID: 29097100
[No Abstract] [Full Text] [Related]
14. Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
Bhindi B; Boorjian SA
Eur Urol; 2018 Mar; 73(3):e53. PubMed ID: 29246642
[No Abstract] [Full Text] [Related]
15. Reply to Lorenzo Marconi, Steven MacLennan, Thomas B.L. Lam, et al's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
Derweesh IH; Mir MC; Autorino R
Eur Urol; 2017 Sep; 72(3):e61-e62. PubMed ID: 28642021
[No Abstract] [Full Text] [Related]
16. Reply to Zhenjie Wu and Linhui Wang's Letter to the Editor re: Riccardo Bertolo, Riccardo Autorino, Giuseppe Simone, et al. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group). Eur Urol 2018;74:226-32.
Bertolo R; Autorino R
Eur Urol; 2018 Dec; 74(6):e147-e148. PubMed ID: 30193967
[No Abstract] [Full Text] [Related]
17. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?
Delahunt B; Samaratunga H; Egevad L
Eur Urol; 2021 May; 79(5):e141-e142. PubMed ID: 33612375
[No Abstract] [Full Text] [Related]
18. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
[No Abstract] [Full Text] [Related]
19. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
[No Abstract] [Full Text] [Related]
20. Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Julien Dagenais, Matthew J. Maurice, Pascal Mouracade, Onder Kara, Ercan Malkoc, Jihad J. Kaouk. Excisional Precision Matters: Understanding the Influence of Excisional Volume Loss on Renal Function After Partial Nephrectomy. Eur Urol 2017;72:168-70.
Dagenais J; Kaouk JH
Eur Urol; 2017 Nov; 72(5):e133-e134. PubMed ID: 28558943
[No Abstract] [Full Text] [Related]
[Next] [New Search]